P&T Perspectives
Real P&T Professionals. Real Market Research.
- Predict P&T Committee Decisions and Competitive Positioning: Forecast how P&T committees may evaluate your drug against competitors to inform market access strategy.
- Understand Pricing Impact on Formulary Placement: Analyze how drug pricing and contracting strategies influence formulary positioning, tier status, and coverage decisions.
- Identify Potential Coverage Restrictions: Anticipate payer restrictions—such as prior authorization and step therapy—for your therapy and competing products.
- Improve Launch Strategy: Optimize your drug’s launch trajectory by identifying the most competitive contracting scenarios.
Gain Insights from Real P&T Professionals
What Our Clients Are Saying
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
How We Can Help
MMIT’s industry-leading P&T panel is composed of pharmacy decision-makers from health plans, pharmacy benefit managers (PBMs), providers, and integrated delivery systems (IDNs). With 100% of panelists actively participating in P&T committees or directly controlling pharmaceutical access within their organizations, MMIT delivers unparalleled visibility into payer decision-making, formulary access, and market access strategy.
P&T Perspectives enables your team to forecast how real P&T committee members will evaluate your drug by simulating an authentic review that reveals competitive positioning and payer decision‑making dynamics.
P&T Perspectives provides direct insight into how pricing and clinical value influence formulary placement by showing how pharmacy and medical decision‑makers assess financial impact and therapeutic differentiation.
P&T Perspectives helps you anticipate likely coverage restrictions—such as prior authorization, step therapy, and contracting requirements—by identifying the controls P&T stakeholders would apply during a simulated committee review.
Key Insights From MMIT
Strategies for Early Market Access Planning
This webinar explores how pharmaceutical companies are moving market access planning earlier into phases 1–3 to improve launch readiness, payer alignment, and long-term commercial performance. Speakers discuss how growing competition, pricing pressure, and regulatory changes are increasing the need for early, data-driven access strategy built on analog analysis, payer research, and integrated real-world data. The session also highlights how these insights help manufacturers refine value propositions, shape clinical development decisions, anticipate payer behavior, and strengthen commercialization strategy before launch.
What you’ll learn:
- How historic analogs can help your team decide whether to pursue or license a product.
- When early identification of payer priorities can lead to beneficial adjustments to your product’s value proposition.
- What kind of data helps you anticipate (and circumvent) launch disadvantages.
Solutions to Support Your Strategy
Strengthen P&T Perspectives by leveraging complementary solutions that deliver comprehensive insights into market dynamics, payer messaging, real-time stakeholder feedback, and strategic launch planning. These offerings empower your team to translate intelligence into decisive, well-informed strategies.